Get the Stockscreener App
4.46
1.83%
0.08
After Hours:
4.46
Lifemd Inc stock is traded at $4.46, with a volume of 567.03K.
It is up +1.83% in the last 24 hours and down -7.66% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$4.38
Open:
$4.39
24h Volume:
567.03K
Relative Volume:
1.20
Market Cap:
$183.04M
Revenue:
$152.55M
Net Income/Loss:
$-20.60M
P/E Ratio:
-4.2885
EPS:
-1.04
Net Cash Flow:
$86,900
1W Performance:
+3.48%
1M Performance:
-7.66%
6M Performance:
-64.35%
1Y Performance:
-37.27%
1-Day Range:
$4.20
$4.49
1-Week Range:
$3.99
$4.50
52-Week Range:
$3.99
$12.88
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-22 | Initiated | Colliers Securities | Buy |
| Oct-04-21 | Resumed | B. Riley Securities | Buy |
Lifemd Inc Stock (LFMD) Latest News
Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.00 - Defense World
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Buy" by Brokerages - MarketBeat
LifeMD announces board member resignation By Investing.com - Investing.com Australia
LifeMD announces board member resignation - Investing.com India
LifeMD stock touches 52-week low at $4.03 amid market challenges - Investing.com Canada
LifeMD Shares Decline Even After the Launch of Testosterone Therapy - MSN
LifeMD® To Report Third Quarter 2024 Financial Results On November 7 - Barchart
LifeMD launches TestoRx, direct to consumer testosterone replacement therapy - Yahoo Finance
LifeMD® to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering - Yahoo Finance
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
Trading Day Review: LifeMD Inc (LFMD) Gains Momentum, Closing at 4.64 - The Dwinnex
LifeMD shares hold as BTIG maintains $12 target - Investing.com India
LifeMD shares hold as BTIG maintains $12 target By Investing.com - Investing.com South Africa
Is it possible to buy LifeMD Inc(LFMD) shares at a good price now? - US Post News
LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions - Yahoo Finance
LifeMD Inc [LFMD] stock for 14,790 USD was bought by Galluppi Stefan - Knox Daily
LifeMD Inc (LFMD) Stock: A Year of Declines and Increases - The InvestChronicle
Financial Health Check: Examining LifeMD Inc (LFMD)’s Key Ratios - The Dwinnex
LifeMD shares maintain Buy rating from B.Riley amid market demand By Investing.com - Investing.com South Africa
LifeMD Inc (LFMD) Q2 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD shares maintain Buy rating from B.Riley amid market demand - Investing.com
Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) PT at $12.00 - MarketBeat
LifeMD Inc (LFMD)’s results reveal risk - US Post News
Trend Tracker for (LFMDP) - Stock Traders Daily
LifeMD stock well-positioned as branded prescriptions gain traction – BTIG By Investing.com - Investing.com Canada
LifeMD Inc [LFMD] stock for 14,790 USD was acquired by Galluppi Stefan - Knox Daily
LifeMD stock well-positioned as branded prescriptions gain traction – BTIG - Investing.com
Balance Sheet Insights: LifeMD Inc (LFMD)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
LifeMD stock touches 52-week low at $4.65 amid market challenges - Investing.com Canada
LifeMD (NASDAQ:LFMD) shareholders are still up 522% over 5 years despite pulling back 11% in the past week - Simply Wall St
XTX Topco Ltd Takes Position in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
LifeMD's SWOT analysis: telehealth firm's stock surges on weight loss success - Investing.com
LifeMD, Inc. (NASDAQ:LFMD) Shares Bought by Deerfield Management Company L.P. Series C - Defense World
Cubist Systematic Strategies LLC Boosts Stock Position in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
Rhumbline Advisers Purchases New Shares in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
Learn to Evaluate (LFMD) using the Charts - Stock Traders Daily
LifeMD Inc [LFMD] Shares Fall -9.15 % on Wednesday - Knox Daily
Balance Sheet Breakdown: LifeMD Inc (LFMD)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
LifeMD, Inc. (NASDAQ:LFMDP) Plans $0.55 Quarterly Dividend - Defense World
Cantor Fitzgerald Maintains LifeMD (LFMD) Overweight Recommendation - MSN
LifeMD Inc’s Banking’s 100-Day Moving Average at 6.85: Will the Stock Break Through? - The InvestChronicle
Have you been able to find a good deal on LifeMD Inc’s shares? - US Post News
(LFMDP) Proactive Strategies - Stock Traders Daily
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - StockTitan
LifeMD: Are The Commons Too Cheap? (NASDAQ:LFMD) - Seeking Alpha
LifeMD Inc (LFMD) Becoming More Attractive for Investors - Knox Daily
LifeMD Inc (NASDAQ: LFMD) – An Analysis Is What You Need - Stocks Register
LifeMD (NASDAQ:LFMD) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lifemd Inc Stock (LFMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jindal Piyush | Director |
Nov 06 '23 |
Option Exercise |
2.52 |
37,500 |
94,500 |
337,500 |
2.66%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):